NCT01514578

Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males

A Multi-Part, Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TRV130A in Healthy Adult Males

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 74 (actual)
• Sponsor: Trevena Inc. · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	TRV130A	Intravenous infusion of 1 hour duration
DRUG	Dextrose in Water	Intravenous infusion of 1 hour duration

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-07-01
• Completion: 2012-07-01
• First posted: 2012-01-23
• Last updated: 2012-08-24

Locations

1 site across 1 country: United States